Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,876,263 |
|
|||||
| News | - | ||||||
| Day High | 11.26 | Low High |
|||||
| Day Low | 11.03 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Dynavax Technologies Corp | DVAX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.16 | -1.43% | 11.01 | 18:40:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 11.11 | 11.03 | 11.26 | 11.21 | 11.17 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,531 | 1,876,263 | US$ 11.19 | US$ 20,993,694 | - | 10.06 - 15.15 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:40:21 | formt | 140 | US$ 11.01 | USD |
Dynavax Technologies Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.46B | 130.61M | - | 232.28M | -6.39M | -0.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Dynavax Technologies News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DVAX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.30 | 12.08 | 11.03 | 11.70 | 3,333,626 | -0.29 | -2.57% |
| 1 Month | 12.40 | 12.67 | 11.03 | 11.81 | 2,121,994 | -1.39 | -11.21% |
| 3 Months | 12.76 | 13.265 | 11.03 | 12.26 | 1,957,582 | -1.75 | -13.71% |
| 6 Months | 13.97 | 15.15 | 11.03 | 13.04 | 1,884,243 | -2.96 | -21.19% |
| 1 Year | 10.68 | 15.15 | 10.06 | 13.19 | 1,747,681 | 0.33 | 3.09% |
| 3 Years | 9.66 | 21.39 | 7.09 | 12.96 | 2,180,044 | 1.35 | 13.98% |
| 5 Years | 6.56 | 21.39 | 1.80 | 9.82 | 2,624,481 | 4.45 | 67.84% |
Dynavax Technologies Description
| Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. |
